Seno

Seno Medical Instruments is a medical imaging company dedicated to developing and commercializing a new paradigm for cancer diagnosis: optoacoustic imaging. Seno Medical's Imagio breast imaging system, which received FDA approval in 2021, combines optoacoustic technology with ultrasound (OA/US) to generate real-time functional and anatomical images of the breast.